Journal of Applied Physiology Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 106: 631-639, 2009. First published November 26, 2008; doi:10.1152/japplphysiol.90971.2008
8750-7587/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/2/631    most recent
90971.2008v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, J.-N.
Right arrow Articles by Fredholm, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, J.-N.
Right arrow Articles by Fredholm, B. B.

Mice heterozygous for both A1 and A2A adenosine receptor genes show similarities to mice given long-term caffeine

Jiang-Ning Yang,1,2 Olga Björklund,1 Karin Lindström-Törnqvist,1 Eva Lindgren,1 Therese M. Eriksson,1 Johan Kahlström,1 Jiang-Fan Chen,3 Michael A. Schwarzschild,4 Irene Tobler,5 and Bertil B. Fredholm1

1Department of Physiology and Pharmacology and 2Department of Surgical Science, Karolinska Institutet, Stockholm, Sweden; 3Department of Neurology, Boston University School of Medicine, Boston; 4Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, Massachusetts; and 5Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland

Submitted 29 July 2008 ; accepted in final form 23 November 2008

Caffeine is believed to exert its stimulant effects by blocking A2A and A1 adenosine receptors (A2AR and A1R). Although a genetic knockout of A2AR eliminates effects of caffeine, the phenotype of the knockout animal does not resemble that of caffeine treatment. In this study we explored the possibility that a mere reduction of the number of A1Rs and A2ARs, achieved by deleting one of the two copies of the A1R and A2AR genes, would mimic some aspects of long-term caffeine ingestion. The A1R and A2AR double heterozygous (A1R-A2AR dHz) mice indeed had approximately one-half the number of A1R and A2AR, and there were little compensatory changes in A2B or A3 adenosine receptor (A2BR or A3R) expression. The ability of a stable adenosine analog to activate receptors was shifted to the right by caffeine and in A1R-A2AR dHz tissue. Caffeine (0.3 g/l in drinking water for 7–10 days) and A1R-A2AR dHz genotype increased locomotor activity (LA) and decreased heart rate without significantly influencing body temperature. The acute stimulatory effect of a single injection of caffeine was reduced in A1R-A2AR dHz mice and in mice treated long term with oral caffeine. Thus at least some aspects of long-term caffeine use can be mimicked by genetic manipulation of the A1R and A2AR.

knockout; locomotor activity; tolerance; receptor binding; lipolysis



Address for reprint requests and other correspondence: J.N. Yang, Dept. of Physiology and Pharmacology, Section of Molecular Neuropharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden (e-mail: jiangning.yang{at}ki.se)




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
L. Yu, J. E. Coelho, X. Zhang, Y. Fu, A. Tillman, U. Karaoz, B. B. Fredholm, Z. Weng, and J.-F. Chen
Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2A receptor knockout mice with microarray profiling
Physiol Genomics, May 13, 2009; 37(3): 199 - 210.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.